68 related articles for article (PubMed ID: 2103353)
1. Limited sampling models for HA-1A IgM monoclonal antibody.
Hardin JM; Khazaeli MB; Allen IE; Dating C; LoBuglio AF
Hum Antibodies Hybridomas; 1990; 1(2):115-9. PubMed ID: 2103353
[TBL] [Abstract][Full Text] [Related]
2. Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humans.
Khazaeli MB; Wheeler R; Rogers K; Teng N; Ziegler E; Haynes A; Saleh MN; Hardin JM; Bolmer S; Cornett J
J Biol Response Mod; 1990 Apr; 9(2):178-84. PubMed ID: 2341860
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibody HA-1A binds to endotoxin via an epitope in the lipid A domain of lipopolysaccharide.
Bogard WC; Siegel SA; Leone AO; Damiano E; Shealy DJ; Ely TM; Frederick B; Mascelli MA; Siegel RC; Machielse B
J Immunol; 1993 May; 150(10):4438-49. PubMed ID: 7683319
[TBL] [Abstract][Full Text] [Related]
4. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis.
Smith CR; Straube RC; Ziegler EJ
Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120
[TBL] [Abstract][Full Text] [Related]
5. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
[TBL] [Abstract][Full Text] [Related]
6. Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.
Fisher CJ; Zimmerman J; Khazaeli MB; Albertson TE; Dellinger RP; Panacek EA; Foulke GE; Dating C; Smith CR; LoBuglio AF
Crit Care Med; 1990 Dec; 18(12):1311-5. PubMed ID: 2245602
[TBL] [Abstract][Full Text] [Related]
7. Limited sampling model for vinblastine pharmacokinetics.
Ratain MJ; Vogelzang NJ
Cancer Treat Rep; 1987 Oct; 71(10):935-9. PubMed ID: 3652057
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies of monoclonal anti-lipid A antibody XMMEN-0E5.
Harkonen S; Kennedy D; Greenberg R
Prog Clin Biol Res; 1988; 272():395-406. PubMed ID: 3293083
[No Abstract] [Full Text] [Related]
9. The HA-1A monoclonal antibody for gram-negative sepsis.
N Engl J Med; 1991 Jul; 325(4):279-83. PubMed ID: 2057029
[No Abstract] [Full Text] [Related]
10. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.
Shen M; Schilder RJ; Obasaju C; Gallo JM
Cancer Chemother Pharmacol; 2002 Sep; 50(3):243-50. PubMed ID: 12203107
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules.
Frödin JE; Lefvert AK; Mellstedt H
Cancer Res; 1990 Aug; 50(16):4866-71. PubMed ID: 2379151
[TBL] [Abstract][Full Text] [Related]
13. Limited sampling model for area under the concentration time curve of total topotecan.
Minami H; Beijnen JH; Verweij J; Ratain MJ
Clin Cancer Res; 1996 Jan; 2(1):43-6. PubMed ID: 9816088
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal anti-lipid A IgM antibodies HA-1A and E-5 recognize distinct epitopes on lipopolysaccharide and lipid A.
Fujihara Y; Bogard WC; Lei MG; Daddona PE; Morrison DC
J Infect Dis; 1993 Dec; 168(6):1429-35. PubMed ID: 7504034
[TBL] [Abstract][Full Text] [Related]
15. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.
Mascelli MA; Frederick B; Ely T; Neblock DS; Shealy DJ; Pak KY; Daddona PE
Infect Immun; 1993 May; 61(5):1756-63. PubMed ID: 8478065
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic significance of antibodies to lipid A in patients with chronic kidney infections].
Altŭnkova I; Robeva R; Bocheva S; Tsekova D; Neshev Kh
Vutr Boles; 1989; 28(1):60-5. PubMed ID: 2741442
[TBL] [Abstract][Full Text] [Related]
18. Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.
Langers P; Press RR; den Hartigh J; Cremers SC; Baranski AG; Lamers CB; Hommes DW; van Hoek B
Ther Drug Monit; 2008 Aug; 30(4):456-61. PubMed ID: 18641539
[TBL] [Abstract][Full Text] [Related]
19. Comparison of binding specificity and the function of two human IgM anti-lipid A monoclonal antibodies.
Wisniewski MA; Kazemi M; Fang IS; Knight LS; Huntenburg CC; Bubbers JE; Schneidkraut MJ
Circ Shock; 1994 Dec; 44(4):230-7. PubMed ID: 7543030
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy.
Colnot DR; Wilhelm AJ; Cloos J; Roos JC; de Bree R; Quak JJ; Snow GB; van Dongen GA
J Nucl Med; 2001 Sep; 42(9):1364-7. PubMed ID: 11535726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
